Gainers
- Valneva VALN stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion.
- Adamis Pharmaceuticals ADMP stock increased by 33.62% to $1.51. The company's market cap stands at $224.8 million.
- MeiraGTx Hldgs MGTX stock rose 15.89% to $16.55. The market value of their outstanding shares is at $733.4 million.
- Agile Therapeutics AGRX stock rose 15.78% to $0.88. The market value of their outstanding shares is at $81.8 million.
- Oyster Point Pharma OYST stock moved upwards by 13.97% to $15.5. The market value of their outstanding shares is at $403.2 million.
- Eyenovia EYEN stock moved upwards by 8.49% to $5.75. The company's market cap stands at $149.2 million.
Losers
- Revance Therapeutics RVNC shares decreased by 33.07% to $15.2 during Monday's pre-market session. The company's market cap stands at $1.0 billion.
- Avadel Pharmaceuticals AVDL shares decreased by 22.43% to $7.75. The company's market cap stands at $454.1 million.
- MannKind MNKD shares declined by 18.08% to $4.17. The company's market cap stands at $1.0 billion.
- Omeros OMER shares fell 16.56% to $6.45. The market value of their outstanding shares is at $403.0 million.
- Aditxt ADTX stock decreased by 14.84% to $1.55. The company's market cap stands at $32.6 million.
- Molecular Templates MTEM shares decreased by 9.31% to $5.75. The market value of their outstanding shares is at $322.8 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
AGRXAgile Therapeutics Inc COM PAR $0.0001
$1.49-1.32%
AVDLAvadel Pharmaceuticals PLC
$7.642.00%
EYENEyenovia Inc
$0.0424-27.4%
MGTXMeiraGTx Holdings PLC
$6.393.40%
MNKDMannKind Corp
$6.090.02%
MTEMMolecular Templates Inc
$0.040013233.3%
OMEROmeros Corp
$8.96-0.39%
RVNCRevance Therapeutics Inc
$3.650.27%
VALNValneva SE
$4.80-1.03%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in